Valeant Pharmaceuticals to Acquire Sanofi Unit, Dermik, for $425 million

The deal announced Monday, July 11 for the French pharmaceutical company, Sanofi, to sell off its  its dermatology unit, Dermik Laboratories, Inc., to Canada-based Valeant Pharmaceuticals International Inc. (VRX) for $425 million in cash. The acquisition involves Dermik’s assets, comprising of an aesthetic and therapeutic dermatology business in the U.S. and Canada, along with other aesthetic dermatology businesses in other parts of the world.  The transaction will also include and a manufacturing facility in Laval near Montreal. Dermik was reported to have revenues of $206 million.

If you are interested in further details about this transaction, please check out our deal profile below.

Valeant to buy Dermik division from Sanofi

Advertisements

About Bourne Partners

As a healthcare-focused merchant bank, Bourne Partners provides financial advisory, direct investment, alternative assets and management consulting services to our client-partners. We play an active role in helping businesses grow by creating long-term, profitable relationships that extend beyond single transactions. It is our focus on relationships and long-term results that has yielded us an impeccable track record of client satisfaction . Our direct and indirect investments in sector-leading companies – often through our relationships with top-tier Private Equity funds – allow us to learn about the best-of-the-best from the inside and apply that knowledge to the companies we serve. At Bourne Partners, we operate within a specific set of core boundaries: integrity, accountability, teamwork, loyalty and commitment are the driving forces behind everything we do.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s